Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases

Лисицyна Т. А., Велтишчев Д. Y., Серавина О. Ф., Ковалевскайа О. Б., Старовоyтова М. Н., Десинова О. В., Абрамкин А. А., Овчаров П. С., Васил'ев В. И., Алекберова З. С., Краснов В. Н., Насонов Е. Л.
Терапевтический архив
Т. 90, Вып. 5, С. 30-37
Опубликовано: 2018
Тип ресурса: Статья

DOI:10.26442/terarkh201890530-37

Аннотация:
Research objective - comparative analysis of incidence and structure of anxiety-depressive spectrum disorders (ADD) in patients with various rheumatic diseases (RD). Materials and methods. 613 patients with RD were enrolled in the study: 180 with a reliable diagnosis of systemic lupus erythematosus (SLE), 128 with rheumatoid arthritis (RA), 110 with systemic sclerosis (SSc), 115 with Behcet's disease (BD), 80 with primary Sjögren's syndrome (pSS). Female prevailed in all groups (95[%] of patients with pSS, 88,2[%] - SSc, 87,2[%] - RA, 85,5[%] of SLE) except BD patients (70[%] male). The mean age was 42.3±1.54 years and was lower in patients with BD (33.3±0.98 years) and SLE (34.6±0.93 years) compared to patients with SSc (49.9±2.47 years), RA (47.4±0.99 years) and pSS (46.2±2.3 years). The mean RD duration was 130,0±8,65 months and was more at BD - 148,5±10,4 months, pSS - 141,6±8,92 months, RA - 138,4±10,1months, and less at SLE - 134,9±8,8 months and SSc - 87,0±5,04 months. The mean SLE activi
Ключевые слова:
Anxietydepressive disorder; Behcet's disease; Diagnostics; Occurrence; Primary sjogren's syndrome; Rheumatoid arthritis; Systemic lupus erythematosus; Systemic sclerosis
adult; anxiety; complication; depression; female; human; male; psychology; rheumatic disease; rheumatoid arthritis; Sjoegren syndrome; systemic lupus erythematosus; Adult; Anxiety; Arthritis, Rheumatoid; Depression; Female; Humans; Lupus Erythematosus, Systemic; Male; Rheumatic Diseases; Sjogren's Syndrome
Язык текста: Русский
ISSN: 2309-5342
Лисицyна Т. А.
Велтишчев Д. Y. Д.Ю.
Серавина О. Ф.
Ковалевскайа О. Б.
Старовоyтова М. Н.
Десинова О. В.
Абрамкин А. А.
Овчаров П. С.
Васил'ев В. И.
Алекберова З. С.
Краснов В. Н.
Насонов Е. Л. Евгений Львович 1948-
Lisitsyna T. A.
Veltishchev D. Y. D.Yu.
Seravina O. F.
Kovalevskaya O. B.
Starovoytova M. N.
Desinova O. V.
Abramkin A. A.
Ovcharov P. S.
Vasil'ev V. I.
Alekberova Z. S.
Krasnov V. N.
Nasonov E. L. Evgenij L`vovich 1948-
Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases
Текст визуальный непосредственный
Терапевтический архив
Медицинское маркетинговое агентство "МедиаМедика"
Т. 90, Вып. 5 С. 30-37
2018
Статья
Anxietydepressive disorder Behcet's disease Diagnostics Occurrence Primary sjogren's syndrome Rheumatoid arthritis Systemic lupus erythematosus Systemic sclerosis
adult anxiety complication depression female human male psychology rheumatic disease rheumatoid arthritis Sjoegren syndrome systemic lupus erythematosus Adult Anxiety Arthritis, Rheumatoid Depression Female Humans Lupus Erythematosus, Systemic Male Rheumatic Diseases Sjogren's Syndrome
Research objective - comparative analysis of incidence and structure of anxiety-depressive spectrum disorders (ADD) in patients with various rheumatic diseases (RD). Materials and methods. 613 patients with RD were enrolled in the study: 180 with a reliable diagnosis of systemic lupus erythematosus (SLE), 128 with rheumatoid arthritis (RA), 110 with systemic sclerosis (SSc), 115 with Behcet's disease (BD), 80 with primary Sjögren's syndrome (pSS). Female prevailed in all groups (95[%] of patients with pSS, 88,2[%] - SSc, 87,2[%] - RA, 85,5[%] of SLE) except BD patients (70[%] male). The mean age was 42.3±1.54 years and was lower in patients with BD (33.3±0.98 years) and SLE (34.6±0.93 years) compared to patients with SSc (49.9±2.47 years), RA (47.4±0.99 years) and pSS (46.2±2.3 years). The mean RD duration was 130,0±8,65 months and was more at BD - 148,5±10,4 months, pSS - 141,6±8,92 months, RA - 138,4±10,1months, and less at SLE - 134,9±8,8 months and SSc - 87,0±5,04 months. The mean SLE activi